Related Experiment Videos
Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1
1Department of Experimental Therapeutics, Division of Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA.
Abstract:
The impact of the cyclin dependent kinase (CDK) inhibitors p21Waf1 and p27Kip1 on paclitaxel-mediated cytotoxicity was investigated in RKO human colon adenocarcinoma cells with the ecdysone-inducible expression of p21Waf1 or p27Kip1. Ectopic expression of p27Kip1 arrested cells at G1 phase, whereas p21Waf1 expression arrested cells at G1 and G2. Expression of p21Waf1 after paclitaxel treatment produced much greater resistance to paclitaxel than did expression of p27Kip1. We attributed this difference to the additional block at G2 induced by p21Waf1, which prevented cells from entering M phase and becoming paclitaxel susceptible. Expression of p21Waf1 inhibited p34cdc2 activity and markedly reduced paclitaxel-mediated mitotic arrest, from 87.5 to 23%. In contrast, p27Kip1 expression also inhibited p34cdc2 but reduced mitotic arrest only slightly, from 87. 4 to 74.5%. We concluded that the G2 block produced by p21Waf1, but not by p27Kip1, contributed to their unequal modulation of sensitivity to paclitaxel-mediated apoptosis in RKO cells, and there is no causal relationship between paclitaxel-mediated cytotoxicity and elevation of p34cdc2 activity.
Insights
Cyclin-dependent kinase (CDK) inhibitors p21Waf1 and p27Kip1 differentially affect paclitaxel cytotoxicity. The G2 cell cycle block by p21Waf1 confers greater resistance to paclitaxel than p27Kip1.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cyclin-dependent kinase (CDK) inhibitors are crucial regulators of the cell cycle.
- Paclitaxel is a widely used chemotherapy agent that targets M phase.
- Understanding how CDK inhibitors modulate drug sensitivity is vital for cancer therapy.
Purpose of the Study:
- To investigate the distinct effects of p21Waf1 and p27Kip1 on paclitaxel-induced cytotoxicity in RKO human colon adenocarcinoma cells.
- To elucidate the cell cycle mechanisms underlying differential drug resistance mediated by these CDK inhibitors.
Main Methods:
- Utilized ecdysone-inducible systems for controlled expression of p21Waf1 and p27Kip1 in RKO cells.
- Assessed cell cycle distribution (G1, G2, M phases) following inhibitor expression and paclitaxel treatment.
- Measured paclitaxel-mediated cytotoxicity and p34cdc2 kinase activity.
Main Results:
- p27Kip1 expression induced G1 arrest, while p21Waf1 caused arrest at both G1 and G2 phases.
- p21Waf1 expression led to significantly greater resistance to paclitaxel compared to p27Kip1.
- p21Waf1 inhibited p34cdc2 activity and markedly reduced paclitaxel-induced mitotic arrest (87.5% to 23%), whereas p27Kip1 had a lesser effect (87.4% to 74.5%).
Conclusions:
- The G2 cell cycle block induced by p21Waf1, but not p27Kip1, is a key factor in conferring resistance to paclitaxel-mediated apoptosis.
- Differential cell cycle arrest mechanisms by p21Waf1 and p27Kip1 explain their unequal impact on paclitaxel sensitivity.
- No direct causal relationship exists between paclitaxel-mediated cytotoxicity and elevated p34cdc2 activity.